跳到正文
Jose Fernando Moura, PhD· @FernandoOnco · X·· 14 小时前评分70

DELLPHI-305

正文 · 原文

DeLLphi-305 delivered the data, but Dr. Stephen Liu DeLLivered the oracle! 🔥
Just like Delphi in ancient Greece, he turned complex findings into wisdom.
A GIANT discussion by a giant in thoracic oncology! 👏
#ESMO26 @myESMO #SCLC
@StephenVLiu @BalazsHalmosMD @OncoAlert @lungoncdoc

70 浏览 · 3 赞 · 2 转发 · 0 回复

会议摘要
LBA3按 Presidential Symposium I 对上

Tarlatamab plus durvalumab (durva) vs durva as 1L maintenance (1LM) therapy following durva, platinum, and etoposide (1L durva + EP) in extensive-stage small cell lung cancer (ES-SCLC): Primary analysis of the phase 3 DeLLphi-305 trial

https://esmocongress.esmo.org

来源:Jose Fernando Moura, PhD · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org